Ebrahim Haroon

10.1k total citations · 3 hit papers
77 papers, 7.3k citations indexed

About

Ebrahim Haroon is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Ebrahim Haroon has authored 77 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Biological Psychiatry, 38 papers in Behavioral Neuroscience and 21 papers in Experimental and Cognitive Psychology. Recurrent topics in Ebrahim Haroon's work include Tryptophan and brain disorders (47 papers), Stress Responses and Cortisol (38 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Ebrahim Haroon is often cited by papers focused on Tryptophan and brain disorders (47 papers), Stress Responses and Cortisol (38 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Ebrahim Haroon collaborates with scholars based in United States, China and Australia. Ebrahim Haroon's co-authors include Andrew H. Miller, Charles L. Raison, Jennifer C. Felger, Bobbi J. Woolwine, Robin E. Rutherford, Shuo Chen, Pamela J. Schettler, Daniel Drake, David R. Goldsmith and Gerard Sanacora and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Pharmacological Reviews.

In The Last Decade

Ebrahim Haroon

75 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

2012 1.2k citations Charles L. Raison, Bobbi J. Woolwine et al. profile →
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

2011 740 citations Ebrahim Haroon, Charles L. Raison et al. Neuropsychopharmacology profile →
CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS

2013 629 citations Andrew H. Miller, Ebrahim Haroon et al. profile →

Peers

Countries citing papers authored by Ebrahim Haroon

Since Specialization

Citations

This map shows the geographic impact of Ebrahim Haroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebrahim Haroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebrahim Haroon more than expected).

Fields of papers citing papers by Ebrahim Haroon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ebrahim Haroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebrahim Haroon. The network helps show where Ebrahim Haroon may publish in the future.

Co-authorship network of co-authors of Ebrahim Haroon

This figure shows the co-authorship network connecting the top 25 collaborators of Ebrahim Haroon. A scholar is included among the top collaborators of Ebrahim Haroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ebrahim Haroon. Ebrahim Haroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia 2025 ·Neuropsychopharmacology ·David R. Goldsmith, (unknown), Gregory P. Strauss, Robin Gross, Jessica A. Cooper, Evanthia C. Wommack, Ebrahim Haroon, Jennifer C. Felger, Elaine F. Walker, Michael T. Treadway, Andrew H. Miller	2
2	Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder 2025 ·Biological Psychiatry ·Andrew H. Miller, Jennifer C. Felger, Ebrahim Haroon	4
3	A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation 2024 ·Molecular Psychiatry ·Michael T. Treadway, (unknown), Jessica A. Cooper, (unknown), (unknown), (unknown), (unknown), Amanda R. Arulpragasam, (unknown), (unknown), (unknown), Evanthia C. Wommack, Bobbi J. Woolwine, Mandakh Bekhbat, Philip A. Kragel, Jennifer C. Felger, Ebrahim Haroon, Andrew H. Miller	11
4	Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study 2022 ·Molecular Psychiatry ·Mandakh Bekhbat, Zhihao Li, (unknown), Michael T. Treadway, Michael J. Lucido, Bobbi J. Woolwine, Ebrahim Haroon, Andrew H. Miller, Jennifer C. Felger	60
5	Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming 2021 ·Molecular Psychiatry ·Mandakh Bekhbat, David R. Goldsmith, Bobbi J. Woolwine, Ebrahim Haroon, Andrew H. Miller, Jennifer C. Felger	20
6	Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder 2020 ·Journal of Psychiatric Research ·Yun‐Ai Su, Jingyu Lin, Qi Liu, Xiaozhen Lv, Gang Wang, Jing Wei, Gang Zhu, Qiaoling Chen, Hongjun Tian, Kerang Zhang, Xueyi Wang, Nan Zhang, Ying Wang, Ebrahim Haroon, (unknown), Tianmei Si	18
7	Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease 2020 ·Neuropsychopharmacology ·Jonathan A. Hollander, Deborah A. Cory‐Slechta, Felice N. Jacka, Steven T. Szabo, Tomás R. Guilarte, Staci D. Bilbo, Carolyn Mattingly, Sheryl S. Moy, Ebrahim Haroon, Mady Hornig, Edward D. Levin, Mikhail V. Pletnikov, Julia L. Zehr, Kimberly A. McAllister, Anika L. Dzierlenga, (unknown), Cindy P. Lawler, Christine Ladd‐Acosta	46
8	Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls 2020 ·Schizophrenia ·David R. Goldsmith, (unknown), Bradley D. Pearce, Evanthia C. Wommack, Alaaeddin Alrohaibani, Neha Goel, Bruce N. Cuthbert, (unknown), Jennifer C. Felger, Ebrahim Haroon, Andrew H. Miller, Erica Duncan	20
9	Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis 2018 ·Brain Behavior and Immunity ·David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Daniel H. Mathalon, Thomas H. McGlashan, Larry J. Seidman, Ming T. Tsuang, Scott W. Woods, Elaine F. Walker, Diana O. Perkins	55
10	TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia 2018 ·Schizophrenia Research ·David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Gregory P. Strauss, P.F. Buckley, Brian J. Miller	100
11	Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder 2018 ·Psychoneuroendocrinology ·Ebrahim Haroon, (unknown), Bobbi J. Woolwine, David R. Goldsmith, Wendy Baer, Evanthia C. Wommack, Jennifer C. Felger, Andrew H. Miller	215
12	Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia 2018 ·Translational Psychiatry ·Ebrahim Haroon, Xiangchuan Chen, Zhihao Li, (unknown), Bobbi J. Woolwine, Xiaoping Hu, Jennifer C. Felger, Andrew H. Miller	80
13	Arginine Vasopressin Effects on Subjective Judgments and Neural Responses to Same and Other-Sex Faces in Men and Women 2017 ·Frontiers in Endocrinology ·James K. Rilling, (unknown), Xiangchuan Chen, (unknown), Ebrahim Haroon, Richmond R. Thompson	20
14	Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder 2016 ·Brain Behavior and Immunity ·David R. Goldsmith, Ebrahim Haroon, Bobbi J. Woolwine, (unknown), Evanthia C. Wommack, Philip D. Harvey, Michael T. Treadway, Jennifer C. Felger, Andrew H. Miller	102
15	Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation 2016 ·Neuropsychopharmacology ·Andrew H. Miller, Ebrahim Haroon, Jennifer C. Felger	117
16	Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation 2014 ·Brain Behavior and Immunity ·Jeremy Weinberger, Charles L. Raison, David B. Rye, (unknown), Bobbi J. Woolwine, Jennifer C. Felger, Ebrahim Haroon, Andrew H. Miller	69
17	Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans 2014 ·Brain Imaging and Behavior ·Chunliang Feng, Patrick D. Hackett, (unknown), Xu Chen, (unknown), Ebrahim Haroon, Beate Ditzen, Giuseppe Pagnoni, James K. Rilling	125
18	Hippocampal Morphology and Distinguishing Late-Onset From Early-Onset Elderly Depression 2007 ·American Journal of Psychiatry ·Martina Ballmaier, Katherine L. Narr, Arthur W. Toga, Virginia Elderkin‐Thompson, Paul M. Thompson, Liberty S. Hamilton, Ebrahim Haroon, Dániel Pham, Andreas Heinz, Anand Kumar	183
19	Gray matter prefrontal changes in type 2 diabetes detected using MRI 2007 ·Journal of Magnetic Resonance Imaging ·Anand Kumar, Ebrahim Haroon, Christine Darwin, Dániel Pham, Olusola Ajilore, (unknown), Jim Mintz	89
20	Cognitive function in adults with type 2 diabetes and major depression 2006 ·Archives of Clinical Neuropsychology ·(unknown), Andrea Letamendi, Virginia Elderkin‐Thompson, Ebrahim Haroon, James J. Miller, Christine Darwin, Ajeet Kumar	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact